Q3: Can I take these medicines if I have type 1 diabetes
Meet the GLP-1 Agonists: Saxenda, Wegovy, Ozempic, and Mounjaro Saxenda , Wegovy , Ozempic , and Mounjaro are part of a powerful group of medications known as GLP-1 receptor agonists a class originally developed to help manage type 2 diabetes, but now widely used (and FDA-approved in many cases) for medical weight loss
Its low 6.6% stockout rate points to healthy supply-side competition most vendors in the cohort price within a narrow band
Patients without diabetes but with obesity will likely be eligible for using this medication especially if the patient is looking for a potent agent with no stimulatory adverse effects
However, these preservatives have a finite lifespan once the vial is in use
Without insurance, costs can be high, but with the right coverage and the prior authorization support Klinic offers, expenses are often reduced significantly